|
animals |
19 |
|
secretin |
14 |
|
humans |
11 |
|
mice |
11 |
|
cell line |
9 |
|
base sequence |
8 |
|
amino acid sequence |
7 |
|
anti-influenza |
7 |
|
antibiotics resistance |
7 |
|
camp |
7 |
|
cell cycle |
7 |
|
cerebellum |
7 |
|
cross-protection |
7 |
|
dissemination potential |
7 |
|
endonuclease activity |
7 |
|
gene regulation |
7 |
|
horizontal gene transfer |
7 |
|
influenza a virus |
7 |
|
metagenomics |
7 |
|
molecular sequence data |
7 |
|
pan-a37s |
7 |
|
pan-a37s/i61t |
7 |
|
pan-a37s/v63i |
7 |
|
polymerase activity |
7 |
|
polymerase assembly |
7 |
|
promoter regions, genetic |
7 |
|
receptors, gastrointestinal hormone - genetics |
7 |
|
secretin receptor |
7 |
|
blotting, western |
6 |
|
carcinogenesis |
6 |
|
ccrk |
6 |
|
cell cycle - physiology |
6 |
|
colorectal cancer |
6 |
|
colorectal neoplasms - etiology |
6 |
|
cyclin-dependent kinases - physiology |
6 |
|
drinking - drug effects |
6 |
|
goldfish |
6 |
|
immunohistochemistry |
6 |
|
in situ hybridization |
6 |
|
neoplasm proteins - physiology |
6 |
|
pacap |
6 |
|
receptors, g-protein-coupled - genetics |
6 |
|
reverse transcriptase polymerase chain reaction |
6 |
|
transcription, genetic |
6 |
|
animal experiment |
5 |
|
antiviral peptide |
5 |
|
body water - physiology |
5 |
|
central nervous system |
5 |
|
chromosome aberrations |
5 |
|
cricetinae |
5 |
|
down-regulation - genetics |
5 |
|
eif4g1 |
5 |
|
epithelial cells - metabolism - pathology |
5 |
|
epstein-barr virus |
5 |
|
gip |
5 |
|
host−virus interaction |
5 |
|
hypothalamic-pituitary axis |
5 |
|
influenza virus |
5 |
|
lmp1 |
5 |
|
medical sciences |
5 |
|
microtubules |
5 |
|
microtubules - metabolism - pathology |
5 |
|
nasopharyngeal epithelial cells |
5 |
|
nf-κb |
5 |
|
osmoregulation |
5 |
|
pb2 |
5 |
|
pituitary adenylate cyclase-activating polypeptide |
5 |
|
pituitary gland, posterior - physiology |
5 |
|
psychiatry and neurology |
5 |
|
rassf1a |
5 |
|
receptors, gastrointestinal hormone - genetics - metabolism |
5 |
|
secretin - blood - genetics - physiology |
5 |
|
tat |
5 |
|
tissue distribution |
5 |
|
tumor suppressor proteins - antagonists and inhibitors - biosynthesis - genetics |
5 |
|
vasopressin |
5 |
|
animal models |
4 |
|
anti-invasion |
4 |
|
antineoplastic activity |
4 |
|
antiproliferation |
4 |
|
biodegradation |
4 |
|
biological evolution |
4 |
|
blood level |
4 |
|
cancer inhibition |
4 |
|
cancer survival |
4 |
|
carrier proteins - genetics - metabolism |
4 |
|
cho cells |
4 |
|
cholesterol - blood |
4 |
|
cricetulus |
4 |
|
cyclodextrins - administration and dosage - chemistry - pharmacokinetics |
4 |
|
db/db mice |
4 |
|
diabetes |
4 |
|
diabetes mellitus, experimental - drug therapy - metabolism - physiopathology |
4 |
|
dna - administration and dosage - chemistry - pharmacokinetics |
4 |
|
down-regulation |
4 |
|
drug carriers - chemistry |
4 |
|
eating - drug effects |
4 |
|
female |
4 |
|
folate |
4 |
|
gene expression |
4 |
|
gene expression regulation |
4 |
|
gene expression regulation - drug effects |
4 |
|
gene therapy |
4 |
|
genome duplication |
4 |
|
glioma |
4 |
|
head rotational movement |
4 |
|
head translational movement |
4 |
|
human neuroblastoma cell |
4 |
|
hypoglycemic agents - pharmacology - therapeutic use |
4 |
|
ifitm1 |
4 |
|
imines - chemistry |
4 |
|
in vivo test |
4 |
|
inferior olive |
4 |
|
intestine |
4 |
|
intracellular signaling peptides and proteins - genetics |
4 |
|
kidney |
4 |
|
liver - cytology - drug effects - metabolism |
4 |
|
male |
4 |
|
melanoma - drug therapy - genetics - metabolism |
4 |
|
mice, inbred c57bl |
4 |
|
mice, knockout |
4 |
|
microsomal triglyceride protein |
4 |
|
molecular evolution |
4 |
|
mutagenesis, site-directed |
4 |
|
neuropeptides - genetics |
4 |
|
nuclear factor i |
4 |
|
pac1 receptor |
4 |
|
pluronic l-81 |
4 |
|
poloxamer - pharmacology - therapeutic use |
4 |
|
polyethylenimine |
4 |
|
promoter |
4 |
|
promoter regions, genetic - genetics |
4 |
|
receptors, gastrointestinal hormone - genetics - physiology |
4 |
|
retinoic acid |
4 |
|
secretin - genetics - metabolism |
4 |
|
secretin - metabolism |
4 |
|
sh-sy5y |
4 |
|
silencer |
4 |
|
sp1 |
4 |
|
structure-activity relationship |
4 |
|
surface-active agents - pharmacology - therapeutic use |
4 |
|
thiazolidinediones - pharmacology - therapeutic use |
4 |
|
transcriptional regulation |
4 |
|
triglycerides - blood |
4 |
|
vestibular nucleus |
4 |
|
vip |
4 |
|
weight loss - drug effects |
4 |
|
β-cyclodextrin |
4 |
|
7,8-dihydroxyflavone |
3 |
|
adenylate cyclase - antagonists and inhibitors |
3 |
|
and teleost |
3 |
|
angiotensin ii |
3 |
|
angiotensin ii - pharmacology |
3 |
|
aquaporin |
3 |
|
aquaporin 2 - metabolism |
3 |
|
aquaporin 4 - metabolism |
3 |
|
aspartic acid |
3 |
|
autism |
3 |
|
biological transport, active |
3 |
|
blotting, southwestern |
3 |
|
body fluids - metabolism |
3 |
|
brain |
3 |
|
calcium |
3 |
|
calcium channels - metabolism |
3 |
|
cardiovascular system - metabolism |
3 |
|
cdk1 |
3 |
|
cdna cloning |
3 |
|
cell culture techniques |
3 |
|
cell line, tumor |
3 |
|
cell membrane - metabolism |
3 |
|
chemical structure |
3 |
|
circumventricular organs |
3 |
|
cpg islands |
3 |
|
cyclic amp - analysis |
3 |
|
cytoplasmic vesicles - metabolism |
3 |
|
cytosensor microphysiometry |
3 |
|
dimerization |
3 |
|
dna - genetics |
3 |
|
dna mutational analysis |
3 |
|
dose-response relationship, drug |
3 |
|
drinking behavior |
3 |
|
electrophoretic mobility shift assay |
3 |
|
epididymis |
3 |
|
epididymis - cytology - drug effects - metabolism |
3 |
|
exons |
3 |
|
fluid homeostasis |
3 |
|
frog |
3 |
|
functional expression |
3 |
|
gastric inhibitory polypeptide - genetics |
3 |
|
ghrh |
3 |
|
ghrh receptor |
3 |
|
ghrhcatfish-like |
3 |
|
ghrhsalmon-like |
3 |
|
glucagon |
3 |
|
gnrh |
3 |
|
goldfish - genetics - metabolism - physiology |
3 |
|
goldfish - physiology |
3 |
|
gonadotropin-ii |
3 |
|
gonadotropin-releasing hormone ii |
3 |
|
growth hormone |
3 |
|
growth hormone - secretion |
3 |
|
growth hormone-releasing hormone - genetics - pharmacology |
3 |
|
gut microbiota |
3 |
|
human secretin receptor |
3 |
|
hypothalamus - drug effects - metabolism |
3 |
|
immunohistochemical staining |
3 |
|
in vivo analysis |
3 |
|
kidney glomerulus - metabolism - pathology |
3 |
|
kidney tubules - metabolism - pathology |
3 |
|
ligands |
3 |
|
male reproductive tract |
3 |
|
map kinase kinase 1 - metabolism |
3 |
|
map kinase kinase 4 - metabolism |
3 |
|
mice, transgenic |
3 |
|
mitochondrial |
3 |
|
models, animal |
3 |
|
mutation |
3 |
|
nasopharyngeal carcinoma |
3 |
|
nasopharyngeal neoplasms - metabolism |
3 |
|
neuropathological diseases |
3 |
|
neuropeptide |
3 |
|
neuropeptides - analysis - pharmacology |
3 |
|
neuropeptides - metabolism - pharmacology - physiology |
3 |
|
nf-κb subunit p65 |
3 |
|
obesity |
3 |
|
pancreas |
3 |
|
pancreas - metabolism |
3 |
|
paraventricular hypothalamic nucleus - drug effects - metabolism |
3 |
|
phenotype |
3 |
|
physiological actions |
3 |
|
pituitary cells |
3 |
|
pituitary gland - chemistry - drug effects - physiology |
3 |
|
pituitary gland - drug effects - metabolism |
3 |
|
pituitary gland - metabolism |
3 |
|
polymerase chain reaction |
3 |
|
polyuria - genetics - physiopathology |
3 |
|
progesterone receptor |
3 |
|
prolactin receptor |
3 |
|
promoter regions, genetic - drug effects |
3 |
|
promotor |
3 |
|
protein kinase a |
3 |
|
protein kinase c |
3 |
|
protein transport |
3 |
|
purkinje cells |
3 |
|
ranidae - genetics - metabolism |
3 |
|
ras-association domain family 1 a (rassf1a) |
3 |
|
rats |
3 |
|
receptors, g-protein-coupled - genetics - metabolism |
3 |
|
receptors, g-protein-coupled - genetics - physiology |
3 |
|
receptors, lhrh - biosynthesis - genetics |
3 |
|
receptors, lhrh - genetics |
3 |
|
receptors, neuropeptide - genetics - physiology |
3 |
|
receptors, pituitary hormone - chemistry - genetics |
3 |
|
receptors, pituitary hormone-regulating hormone - genetics - physiology |
3 |
|
receptors, retinoic acid - physiology |
3 |
|
receptors, vasoactive intestinal peptide - chemistry - genetics - metabolism |
3 |
|
retinoic acid receptors |
3 |
|
retinoid x receptor alpha - physiology |
3 |
|
salmon |
3 |
|
scanning mutation |
3 |
|
secretin - blood - physiology |
3 |
|
secretin - genetics |
3 |
|
secretin - genetics - metabolism - pharmacology |
3 |
|
secretin receptor-deficient mice |
3 |
|
secretin receptors |
3 |
|
secretin/vip/pacap family peptides |
3 |
|
sequence homology, amino acid |
3 |
|
skeletal muscle |
3 |
|
sp transcription factors - metabolism |
3 |
|
sp-proteins |
3 |
|
staining and labeling |
3 |
|
stomach - metabolism |
3 |
|
thymidine kinase - analysis |
3 |
|
tissue distribution - genetics |
3 |
|
tissue-specific expression |
3 |
|
transcription factor ii d |
3 |
|
transcription factor rela - physiology |
3 |
|
transfection |
3 |
|
transgenes |
3 |
|
transgenic mouse |
3 |
|
tretinoin - pharmacology |
3 |
|
tumor suppressor proteins - genetics - metabolism |
3 |
|
ultraviolet rays |
3 |
|
vasopressins - metabolism |
3 |
|
vpac1 receptor |
3 |
|
vpac2 receptor |
3 |
|
water - metabolism |
3 |
|
water drinking behavior |
3 |
|
water homeostasis |
3 |
|
water-electrolyte balance |
3 |
|
water-electrolyte balance - drug effects |
3 |
|
5' flanking region - genetics |
2 |
|
alternative splicing |
2 |
|
amphibians - genetics |
2 |
|
amphioxus |
2 |
|
antigens, cd44 |
2 |
|
appetite regulation - drug effects - genetics - physiology |
2 |
|
arcuate nucleus |
2 |
|
autistic disorder - genetics |
2 |
|
autosomal dominant polycystic kidney disease |
2 |
|
basic helix-loop-helix transcription factors - genetics - metabolism |
2 |
|
bile flow |
2 |
|
binding sites |
2 |
|
biosensing techniques |
2 |
|
brain - embryology - metabolism |
2 |
|
brain region |
2 |
|
bret |
2 |
|
calcium channel |
2 |
|
cancer |
2 |
|
carassius auratus |
2 |
|
cardiovascular physiological phenomena |
2 |
|
cell signaling |
2 |
|
central and peripheral functions |
2 |
|
central nervous system - embryology - metabolism |
2 |
|
cerebellohypothalamic projection |
2 |
|
cerebellum - anatomy & histology - physiology |
2 |
|
cerebellum - cytology - metabolism |
2 |
|
characterization |
2 |
|
cholangiocyte |
2 |
|
choleresis |
2 |
|
chromosome mapping |
2 |
|
class b |
2 |
|
clinical management |
2 |
|
cloning |
2 |
|
cloning, molecular |
2 |
|
cyclic amp |
2 |
|
depolarization-evoked release |
2 |
|
desensitization |
2 |
|
development |
2 |
|
differential expression |
2 |
|
divergence |
2 |
|
dna probes - genetics |
2 |
|
dna, complementary - metabolism |
2 |
|
dna-binding proteins - chemistry - genetics - physiology |
2 |
|
duodenum - metabolism |
2 |
|
edentulous mandible |
2 |
|
embryo |
2 |
|
embryo, mammalian - metabolism |
2 |
|
embryonic development |
2 |
|
endocrine system |
2 |
|
estrogen |
2 |
|
estrogen related receptor alpha |
2 |
|
evolution |
2 |
|
evolution, molecular |
2 |
|
expression |
2 |
|
extracellular acidification rate |
2 |
|
feeding |
2 |
|
feeding behavior - physiology |
2 |
|
feeding behavior - physiology - psychology |
2 |
|
fish proteins - genetics - metabolism - physiology |
2 |
|
fish proteins - genetics - physiology |
2 |
|
fishes - genetics |
2 |
|
fishes - genetics - metabolism |
2 |
|
follicle-stimulating hormone |
2 |
|
follicle-stimulating hormone (fsh) |
2 |
|
g protein-coupled receptor |
2 |
|
gaba |
2 |
|
gastrointestinal tract |
2 |
|
gene duplication |
2 |
|
gene expression regulation - physiology |
2 |
|
gene expression regulation, developmental |
2 |
|
gene silencing - drug effects |
2 |
|
gene structure |
2 |
|
genes, reporter |
2 |
|
genome, human |
2 |
|
glucagon antagonist des-his 1-[nle 9-ala 11-ala 16] |
2 |
|
glucagon receptor |
2 |
|
glucagon-like peptide 1 |
2 |
|
glucagon-like peptides |
2 |
|
glutamate |
2 |
|
gnrh analogs |
2 |
|
gnrh receptor |
2 |
|
goldfish - genetics |
2 |
|
gonadotrope |
2 |
|
gonadotropin |
2 |
|
gonadotropin-releasing hormone - analogs & derivatives - physiology |
2 |
|
gonadotropin-releasing hormone - analogs and derivatives - genetics - metabolism |
2 |
|
gpcr |
2 |
|
growth hormone (gh) |
2 |
|
growth hormone release |
2 |
|
growth hormone-releasing hormone |
2 |
|
growth hormone-releasing hormone-like peptide |
2 |
|
heart |
2 |
|
histaminergic fiber |
2 |
|
human cerebellum |
2 |
|
human gnrh receptor |
2 |
|
human reproduction |
2 |
|
hydrogen-ion concentration |
2 |
|
hypothalamocerebellar projection |
2 |
|
hypothalamus |
2 |
|
hypothalamus - anatomy & histology - physiology |
2 |
|
hypothalamus - cytology - metabolism |
2 |
|
immunity - physiology |
2 |
|
inflammation |
2 |
|
inhibitory postsynaptic currents |
2 |
|
intestines - embryology - metabolism |
2 |
|
intracellular signaling peptides and proteins - chemistry - genetics - metabolism |
2 |
|
introns |
2 |
|
ip3 |
2 |
|
learning |
2 |
|
liver |
2 |
|
lungfish |
2 |
|
luteinizing hormone |
2 |
|
luteinizing hormone (lh) |
2 |
|
machine learning |
2 |
|
macroglossia |
2 |
|
mammals - genetics - metabolism |
2 |
|
mast cell activation |
2 |
|
melanocortin system |
2 |
|
minisatellite repeats |
2 |
|
motor coordination and learning |
2 |
|
motor reflexes |
2 |
|
mouse |
2 |
|
nerve net - physiology |
2 |
|
nerve tissue proteins - genetics - metabolism |
2 |
|
neural development |
2 |
|
neurod |
2 |
|
neuron restrictive silencer factor |
2 |
|
neuropeptides - chemistry - genetics - metabolism |
2 |
|
neuropeptides - pharmacology |
2 |
|
neurotrophic factor |
2 |
|
non-ige–mediated allergies |
2 |
|
oligomerization |
2 |
|
orexin |
2 |
|
orexin receptor |
2 |
|
origin |
2 |
|
ovarian cancer |
2 |
|
ovary |
2 |
|
oxytocin |
2 |
|
pacap-related peptide |
2 |
|
pacap-related peptide (prp) |
2 |
|
pacap/glucagon |
2 |
|
patch clamp |
2 |
|
pathway |
2 |
|
peptide fragments - genetics - metabolism - physiology |
2 |
|
peptide hormone |
2 |
|
peptides - genetics |
2 |
|
phylogeny |
2 |
|
pituitary |
2 |
|
pituitary adenylate cyclase-activating polypeptide (pacap) |
2 |
|
pituitary adenylate cyclase-activating polypeptide - genetics - metabolism - physiology |
2 |
|
pituitary adenylate cyclase-activating polypeptide - physiology |
2 |
|
pituitary gland - cytology - metabolism |
2 |
|
pkc signalling |
2 |
|
polycystic kidney disease |
2 |
|
prenatal |
2 |
|
progesterone |
2 |
|
proglucagon - genetics |
2 |
|
promoter regions (genetics) |
2 |
|
promoter study |
2 |
|
proopiomelanocortin |
2 |
|
protein biosynthesis |
2 |
|
protein precursors - genetics - metabolism - physiology |
2 |
|
protein structure, tertiary |
2 |
|
pth |
2 |
|
purkinje cells - cytology - metabolism |
2 |
|
purkinje specific secretin knockout |
2 |
|
radiotherapy |
2 |
|
receptor |
2 |
|
receptors, cell surface - genetics |
2 |
|
receptors, complement - chemistry - genetics - metabolism |
2 |
|
receptors, cytoplasmic and nuclear - metabolism |
2 |
|
receptors, g-protein-coupled |
2 |
|
receptors, g-protein-coupled - chemistry - genetics - metabolism |
2 |
|
receptors, gastrointestinal hormone - deficiency - genetics - physiology |
2 |
|
receptors, glucagon - genetics - metabolism |
2 |
|
receptors, pituitary adenylate cyclase-activating polypeptide, type i - genetics - physiology |
2 |
|
recombinant proteins - metabolism |
2 |
|
regulatory sequences, nucleic acid |
2 |
|
repressor element 1 |
2 |
|
repressor proteins - physiology |
2 |
|
response elements - genetics |
2 |
|
retrograde messenger |
2 |
|
secretin - administration and dosage - deficiency - physiology |
2 |
|
secretin - biosynthesis |
2 |
|
secretin/pacap/vip peptide family |
2 |
|
sequence alignment |
2 |
|
shrimp |
2 |
|
signal transduction |
2 |
|
skin |
2 |
|
small heterodimer partner |
2 |
|
somatic-visceral integration |
2 |
|
sp-protein |
2 |
|
steroid hormone |
2 |
|
structure |
2 |
|
structure aided drug designing |
2 |
|
synaptic plasticity |
2 |
|
transcription factors |
2 |
|
transcription factors - chemistry - genetics - physiology |
2 |
|
treatment outcome |
2 |
|
variable number of tandem repeats |
2 |
|
visceral afferents - physiology |
2 |
|
16s rrna amplicon sequencing |
1 |
|
5-ht1b receptor |
1 |
|
5-ht2c receptor |
1 |
|
acetylcholine |
1 |
|
adenocarcinoma |
1 |
|
adenylyl cyclase |
1 |
|
adrenal gland |
1 |
|
adrenergic receptors |
1 |
|
air |
1 |
|
air pollution, indoor |
1 |
|
aldosterone |
1 |
|
algorithm |
1 |
|
allergy |
1 |
|
allosteric regulation |
1 |
|
alternative mrna splicing |
1 |
|
aluminum oxide |
1 |
|
and glucagon family peptides |
1 |
|
angiotensin |
1 |
|
anion binding |
1 |
|
anxiety |
1 |
|
apoptosis |
1 |
|
arginine vasopressin |
1 |
|
bacteriophage |
1 |
|
bacteroides |
1 |
|
base composition |
1 |
|
bcl-2 family proteins |
1 |
|
bhk |
1 |
|
bile ducts - drug effects - pathology |
1 |
|
biliary epithelium |
1 |
|
bioinformatics |
1 |
|
biological assay |
1 |
|
bioluminescence resonance energy transfer (bret) |
1 |
|
breast neoplasms |
1 |
|
cardiac hypertrophy |
1 |
|
caspase |
1 |
|
cd36 |
1 |
|
cdna sequence |
1 |
|
cell apoptosis |
1 |
|
cell count |
1 |
|
cell death |
1 |
|
cell division |
1 |
|
cell survival |
1 |
|
ceramic |
1 |
|
ceramics |
1 |
|
cerebellar development |
1 |
|
ceruloplasmin - genetics |
1 |
|
chemotaxis |
1 |
|
cholestasis, extrahepatic - complications - genetics - pathology |
1 |
|
chromogranins |
1 |
|
chromosomes, human, pair 2 |
1 |
|
ck2 |
1 |
|
class b gpcr evolution |
1 |
|
cloning, molecular - methods |
1 |
|
community dynamics |
1 |
|
corticotropin-releasing hormone |
1 |
|
creb |
1 |
|
crh |
1 |
|
crl4cop1 |
1 |
|
csn |
1 |
|
cyp11b2 |
1 |
|
cytokine release |
1 |
|
deoxyribonuclease i |
1 |
|
diet, high-fat - adverse effects |
1 |
|
diet-disease associations |
1 |
|
dietary fats - pharmacokinetics |
1 |
|
diseases |
1 |
|
dna |
1 |
|
dna - genetics - isolation & purification |
1 |
|
dna methylation |
1 |
|
dna, complementary |
1 |
|
dna, neoplasm - chemistry - metabolism |
1 |
|
dopamine |
1 |
|
doppler imaging |
1 |
|
drug target |
1 |
|
drug-induced allergy |
1 |
|
echocardiography |
1 |
|
em66 |
1 |
|
energy homeostasis |
1 |
|
enhancer elements, genetic |
1 |
|
enrichment score |
1 |
|
enterocytes |
1 |
|
epigenetics |
1 |
|
epithelial sodium channels |
1 |
|
equipment design |
1 |
|
erk1/2 |
1 |
|
escherichia coli - metabolism |
1 |
|
estradiol - pharmacology |
1 |
|
estrogen receptor alpha |
1 |
|
exhalation |
1 |
|
expression in e. coli |
1 |
|
eyestalk |
1 |
|
family b |
1 |
|
farnesoic acid o-methyltransferase |
1 |
|
fatty acid metabolism |
1 |
|
feeding behavior |
1 |
|
fibrosis |
1 |
|
fishes |
1 |
|
food and water intake |
1 |
|
food intake |
1 |
|
forskolin |
1 |
|
forskolin - pharmacology |
1 |
|
g protein-coupled estrogen receptor |
1 |
|
g protein-coupled receptor (gpcr) |
1 |
|
g-protein coupled receptor |
1 |
|
gastric inhibitory polypeptide |
1 |
|
gastric inhibitory polypeptide - biosynthesis |
1 |
|
gastrointestinal hormones |
1 |
|
gene organization |
1 |
|
genes |
1 |
|
genes, synthetic |
1 |
|
globus pallidus |
1 |
|
glp |
1 |
|
glp-1 |
1 |
|
glp-2 |
1 |
|
glucagon-like peptide |
1 |
|
glucagon-like peptide-1 |
1 |
|
glucose - metabolism |
1 |
|
glucose homeostasis |
1 |
|
glucose sensing |
1 |
|
glycometabolism |
1 |
|
glycyrrhizic acid |
1 |
|
gonadotropin-releasing hormone - physiology |
1 |
|
gpcr dimerization |
1 |
|
gpcr heteromerization |
1 |
|
gpcr oligomerization |
1 |
|
granular cell migration |
1 |
|
green tea |
1 |
|
growth hormone - genetics |
1 |
|
growth hormone - genetics - metabolism |
1 |
|
growth hormone-releasing hormone receptor |
1 |
|
gtp-binding proteins - metabolism |
1 |
|
gut hormone |
1 |
|
heterogeneity |
1 |
|
heteromer |
1 |
|
high cell density |
1 |
|
histamine |
1 |
|
histamine receptors |
1 |
|
histone modification |
1 |
|
homomer |
1 |
|
hormone sensitive lipase |
1 |
|
human gip |
1 |
|
human-monocyte–derived macrophages (h-mdms) |
1 |
|
hypersensitivity reactions |
1 |
|
hypertonicity |
1 |
|
hypothalamic histaminergic projections |
1 |
|
immobilization |
1 |
|
immune modulation |
1 |
|
in situ hybridization, fluorescence |
1 |
|
influenza, human - transmission |
1 |
|
innate immunity |
1 |
|
intestinal absorption - genetics |
1 |
|
iron chelating agents - metabolism |
1 |
|
issue 121 |
1 |
|
juvenile hormone |
1 |
|
kinetics |
1 |
|
kisspeptin receptor |
1 |
|
knockout mice |
1 |
|
lactates - biosynthesis |
1 |
|
lipolysis |
1 |
|
lipopolysaccharide |
1 |
|
liver - drug effects - pathology |
1 |
|
liver - metabolism |
1 |
|
liver diseases - etiology - pathology |
1 |
|
liver dysfunction |
1 |
|
long chain fatty acid |
1 |
|
mammals - physiology |
1 |
|
masks |
1 |
|
mast cells |
1 |
|
medicine |
1 |
|
mesocricetus |
1 |
|
metabolic diseases |
1 |
|
metabolic role |
1 |
|
metabolism |
1 |
|
metallothionein - genetics |
1 |
|
methyl farnesoate |
1 |
|
methylfarnesoate |
1 |
|
minimal |
1 |
|
mirnas and lncrnas |
1 |
|
molecular neuroendocrinology |
1 |
|
molt inhibiting hormone |
1 |
|
monocyte recruitment |
1 |
|
monocytes |
1 |
|
motor control |
1 |
|
motor learning |
1 |
|
mouse model |
1 |
|
mrgprx2 |
1 |
|
neddylation |
1 |
|
neoplasms - physiopathology |
1 |
|
nerve growth factor |
1 |
|
neural transmission |
1 |
|
neuroendocrine tumor |
1 |
|
neuropeptides |
1 |
|
neuroprotection |
1 |
|
newborns |
1 |
|
nuclear factor of activated t-cells 5 |
1 |
|
nucleic acid hybridization |
1 |
|
o-glcnacylation |
1 |
|
obesity - blood - etiology - genetics - physiopathology |
1 |
|
organ toxicity |
1 |
|
ovarian neoplasms |
1 |
|
overnutrition-associated cancer |
1 |
|
oxygen consumption |
1 |
|
p53 degradation |
1 |
|
pacap/vip receptors |
1 |
|
pancreas - chemistry |
1 |
|
pancreatic neoplasms |
1 |
|
parathyroid hormone |
1 |
|
parathyroid hormone receptor |
1 |
|
patch-clamp |
1 |
|
patient simulation |
1 |
|
perfusion |
1 |
|
perfusion system |
1 |
|
pharmacology |
1 |
|
pheochromocytoma |
1 |
|
phorbol esters |
1 |
|
pka |
1 |
|
pkc |
1 |
|
plasma marker |
1 |
|
porosity |
1 |
|
positive feedback loop |
1 |
|
postprandial triglyceride release |
1 |
|
preproglucagon |
1 |
|
proglucagon |
1 |
|
proglucagon cdna |
1 |
|
promoter regions, genetic - drug effects - genetics |
1 |
|
protein a fusion protein |
1 |
|
protein evolution |
1 |
|
protein sorting signals - biosynthesis - genetics |
1 |
|
protein-protein interaction network |
1 |
|
prothrombin - genetics |
1 |
|
pseudogenes |
1 |
|
purkinje cell morphogenesis |
1 |
|
race |
1 |
|
rapid amplification of cdna ends |
1 |
|
rat |
1 |
|
rats, inbred strains |
1 |
|
receptors, estrogen - physiology |
1 |
|
receptors, gastrointestinal hormone - deficiency - physiology |
1 |
|
recombinant fusion proteins - biosynthesis - isolation & purification |
1 |
|
recombinant fusion proteins - metabolism |
1 |
|
recombinant proteins - biosynthesis |
1 |
|
reduced glutathione |
1 |
|
reproduction |
1 |
|
restriction mapping |
1 |
|
retinoic acid binding protein |
1 |
|
sctr |
1 |
|
secretin (sct) |
1 |
|
secretin angiotensin ii |
1 |
|
secretin family peptides |
1 |
|
secretin family receptors |
1 |
|
secretogranin ii |
1 |
|
sequence homology, nucleic acid |
1 |
|
serotonin |
1 |
|
shrimp reproduction |
1 |
|
social behavioral |
1 |
|
somatostatin |
1 |
|
staphylococcal protein a - metabolism |
1 |
|
staurosporine |
1 |
|
stress |
1 |
|
substrate specificity |
1 |
|
swine |
1 |
|
tachycardia |
1 |
|
te-671 |
1 |
|
terminator regions, genetic |
1 |
|
tetradecanoylphorbol acetate - pharmacology |
1 |
|
thrombin |
1 |
|
thrombin cleavage |
1 |
|
transcription factor ap-1 - metabolism |
1 |
|
transcription, genetic - drug effects |
1 |
|
transferrin |
1 |
|
transferrin - biosynthesis |
1 |
|
transferrin - biosynthesis - chemistry - genetics - isolation & purification |
1 |
|
transferrin - genetics |
1 |
|
transgenic mice |
1 |
|
transmembrane peptides |
1 |
|
transverse aortic banding |
1 |
|
tumor cells, cultured |
1 |
|
type-2 diabetes mellitus |
1 |
|
ubiquitylation |
1 |
|
urocortin |
1 |
|
vasoactive intestinal polypeptide |
1 |
|
vasoactive-intestinal peptide |
1 |
|
vertebrate |
1 |
|
vertebrates - physiology |
1 |
|
vitellogenin |
1 |
|
water and food intake |
1 |
|
xenopus |
1 |
